Hrt Financial LP Matinas Bio Pharma Holdings, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.35 - $0.72 $3,588 - $7,382	10,253 New	10,253 $3,000
Q4 2022 Feb 10, 2023	BUY	$0.46 - $42.69 $19,131 - $1.78 Million	41,590 Added 320.49%	54,567 $27,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $33.0 $8,175 - $428,241	12,977 New	12,977 $8,000
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.1 $557,766 - $818,056	-743,688 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.96 - $1.74 $713,940 - $1.29 Million	743,688 New	743,688 $780,000
Q2 2020 Aug 14, 2020	SELL	$0.52 - $0.92 $38,043 - $67,308	-73,161 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.6 - $2.31 $43,896 - $169,001	73,161 New	73,161 $43,000

2.74M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $143M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.